Prostate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancer
Conditions
Interventions
Sponsors
University of Tsukuba
TSUKUBA Imaging Center ImaginAb, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patient is over 20 years old at the time of informed consent. (2) Karnofsky Performance Status (KPS) is 70 or over (3) Patients who have the following clinical examination AST or ALT is 2.5 fold higher than normal range T-Bil is 1.5 fold higher than normal range Serum albumin is more than 2..0 g/dl Serum creatinine is1.5 fold or less than normal range Creatinine clearance is more than 60 mL/min
Exclusion criteria
Exclusion criteria: (1) In a clinical trial, patients who need to receive the new treatment (2) Patinets with severe pulmonary, renal, gastrointestinal, hematological or psychonurological disease (3) Patients whose doctors determined as inadequate for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety: Subjective and Objective symptom, Vital data, Clinical tests, Radiation exposure, Adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Pharmacokinetics 2) Detection of cancer focus 3) PET imaging condition 4) Imaging of tumor neovascular | — |
Countries
Japan
Contacts
Public ContactAkira Joraku
Faculty of Medicine, University of Tsukuba Department of Urology
Outcome results
None listed